No Picture
Newsmakers

Tonix Pharmaceuticals (NASDAQ: TNXP) Initiates Enrollment in the RESILIENT Study, a Potentially Pivotal Phase 3 Study of TNX-102 SL for the Management of Fibromyalgia

Results from Planned Interim Analysis Expected First Quarter 2023 A Positive Outcome in RESILIENT Together with Results from Previous Positive Phase 3 Study RELIEF May Support Submission of an NDA CHATHAM, N.J., April 07, 2022 […]

Newsmakers

Nextech AR (OTC: NEXCF) Expands 3D Patent Portfolio Files Four Pivotal Non-Provisional Utility Patents

TORONTO, April 06, 2022—-Nextech AR Solutions Corp. (“Nextech” or the “Company”) (OTCQB: NEXCF) (NEO: NTAR) (CSE: NTAR) (FSE: N29), a Metaverse Company and leading provider of augmented reality (“AR”) experience technologies and services is pleased […]

Newsmakers

ORAGIN’s (OTC: OGGFF) Future of Cheese Receives U.S. Food and Drug Administration (FDA) Registration, Allowing for North American Wide Direct Sales

ORAGIN makes stock option grant to a director of the Company with significant industry experience who will take an active role in the development and growth of the Company and its subsidiary Future of Cheese […]

Newsmakers

DeepMarkit (OTC: MKTDF) Attending the North American Carbon World Conference from April 6-8th in Anaheim

The Company also Endorses the SEC’s Ground-Breaking Proposal to Implement a Rule that Would Require all Public Companies to Report Their Carbon Emissions CALGARY, AB, April 6, 2022  – DeepMarkit Corp., (“DeepMarkit” or the “Company”) (TSXV: MKT) […]

CEO Interview

NEXT SUPER STOCK Nextech AR (OTC: NEXCF) (CSE: NTAR) “On-Ramp to Web 3.0 for $5 Trillion E-Commerce Market”

NEXT SUPER STOCK Nextech AR (OTC: NEXCF) (CSE: NTAR) Accelerating E-Commerce Transition to Web 3.0 for $5 Trillion E-Commerce Market – and Unleashing Shareholder Value with New SPINOUT 6/26/22 livestream NEXT SUPER STOCK Nextech AR […]

No Picture
Newsmakers

Sunshine Biopharma’s (NASDAQ: SBFM) Newly Designed mRNA Molecules Prove Effective Against Multidrug Resistant Cancer Cells

A Potential Multi-Billion Dollar Global Market Opportunity for Cancer Treatments MONTREAL, April 05, 2022 — Sunshine Biopharma, Inc. (NASDAQ: SBFM), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, […]

No Picture
Newsmakers

CLINIGENCE HOLDINGS AND NUTEX HEALTH (NASDAQ: NUTX) ANNOUNCE COMPLETION OF MERGER AND LISTING ON THE NASDAQ CAPITAL MARKET

FORT LAUDERDALE, Fla. and HOUSTON, April 4, 2022 /PRNewswire/ — Clinigence Holdings, Inc. (“Clinigence” or the “Company”) (OTC: NUTX), a primary care-centric, technology-enabled, risk-bearing population health management company, and Nutex Health Holdco LLC (“Nutex Holdco”), together with its affiliates […]

Newsmakers

DeepMarkit (OTC: MKTDF) Appoints Oscar Mendoza and Geoffrey Fielding to Advisory Board

The Formation of the Special Advisory Board Strengthens and Guides the Company’s Mission to Democratize Access To Global Carbon Credit Markets CALGARY, AB, March 29, 2022  – DeepMarkit Corp., (“DeepMarkit” or the “Company”) (TSXV: MKT) (OTC: MKTDF) (FRA: DEP), a […]

Healthcare

Pharmadrug (OTC: LMLLF)Advances PD-001, Its Patented, Improved Version of Cepharanthine for Oncology and Infectious Disease

Committed to the ‘pipeline-in-a-pill’ approach with PD-001 for certain cancers and COVID-19 Advances cGMP manufacturing of clinical drug supply with Southwest Research Institute Receives final positive data for recently conducted prostate cancer model and evaluates […]

Spotlight Stocks

Moderna, Inc. (NASDAQ: MRNA) CEO Stephane Bancel: ”Unique Opportunity to Transform Traditional Vaccine Market”

Moderna, Inc. (NASDAQ: MRNA) Vaccines Day Conference CEO Stephane Bancel Comments CEO Stephane Bancel: “…If you just look at the impact of vaccination on health over the last, let’s say, 20 years, it has been […]

CEO Interview

NEXT SUPER STOCK: PharmaDrug (OTC: LMLLF) (CSE: PHRX) Advancing BioPharm Assets w Billion Dollar Markets

NEXT SUPER STOCK: PharmaDrug (OTC: LMLLF) (CSE: PHRX) CEO Daniel Cohen shares update on LMLLF’s Advancing BioPharma pipeline assets addressing billion dollar markets opportunities in cancer, and glaucoma therapeutics. March 30, 2022 livestream     […]